Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Infrared light stimulation of the forehead for autism social and behavior symptoms

Tests non-invasive infrared light applied to the forehead in people with autism.

Plain-language title generated from the registry record
Registry title: Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

Key facts

Where
Austin, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 4 and 60 years old?

Source: NCT06203938, who can take part

Where in United States

  • Seay Psychology Building, Room 3.304Austin, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Francisco Gonzalez-Lima, PhD
Trial code
NCT06203938
Record updated
22 June 2026
Original description
The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).Read full original descriptionShow less

Social and Behavioral Associations With Prefrontal Photobiomodulation in Autism Spectrum

The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).

Inclusion: Age between 4-60 years.

Exclusion: Current pregnancy.

ClinicalTrials.gov NCT06203938